NCT00537862View on ClinicalTrials.gov

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

February 28, 2007

Conditions
Kidney Transplant
Interventions
DRUG

Enteric-Coated Mycophenolate Sodium (EC-MPS)

Trial Locations (8)

(614-735)

Novartis Investigative Site, Busan

(700-712)

Novartis Investigative Site, Daegu

(700-721)

Novartis Investigative Site, Daegu

(501-757)

Novartis Investigative Site, Jeollanam-do

(110-744)

Novartis Investigative Site, Seoul

(120-752)

Novartis Investigative Site, Seoul

(137-701)

Novartis Investigative Site, Seoul

(138-736)

Novartis Investigative Site, Seoul

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY